201 related articles for article (PubMed ID: 3652931)
21. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
Oki JC
Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
[TBL] [Abstract][Full Text] [Related]
22. [The effect of micronized phenofibrate on the lipoproteins of the blood plasma at different initial lipid levels].
Perova NV; Ozerova IN; Kalinina AM; Pavlova LI; Olfer'ev AM; Mel'kina OE; Golubev MA; Oganov RG
Ter Arkh; 1996; 68(1):71-6. PubMed ID: 8644040
[TBL] [Abstract][Full Text] [Related]
23. [Statistical analysis of variations in total cholesterol, HDL, HDL2, HDL3, LDL-cholesterol, VLDL-triglycerides, apo-A and apo-B lipoproteins in dyslipidemias during antilipemic therapy].
Melloni GF; Scarazatti E; Garanzelli P; Melloni R
Boll Soc Ital Biol Sper; 1985 Jan; 61(1):7-14. PubMed ID: 3884023
[TBL] [Abstract][Full Text] [Related]
24. Correlations of plasma high-density lipoprotein cholesterol levels with other plasma lipid and lipoprotein concentrations.
Davis CE; Gordon D; LaRosa J; Wood PD; Halperin M
Circulation; 1980 Nov; 62(4 Pt 2):IV24-30. PubMed ID: 7188560
[TBL] [Abstract][Full Text] [Related]
25. Reduction of serum lipids in familial hyperlipidemias by a tetralin derivative.
Oriente P; Motolese M; Cerqua R; Mancini M
Int Z Klin Pharmakol Ther Toxikol; 1969 Oct; 2(4):348-53. PubMed ID: 4903988
[No Abstract] [Full Text] [Related]
26. Lipid and lipoprotein profile in physiological pregnancy.
Lippi G; Albiero A; Montagnana M; Salvagno GL; Scevarolli S; Franchi M; Guidi GC
Clin Lab; 2007; 53(3-4):173-7. PubMed ID: 17447654
[TBL] [Abstract][Full Text] [Related]
27. Disturbed lipids, lipoproteins and triglyceride-rich lipoproteins as well as fasting and nonfasting non-high-density lipoprotein cholesterol in post-renal transplant patients.
Kimak E; Ksiazek A; Baranowicz-Gaszczyk I; Solski J
Ren Fail; 2007; 29(6):705-12. PubMed ID: 17763166
[TBL] [Abstract][Full Text] [Related]
28. Factors associated with changes in serum total cholesterol levels over 7 years in middle-aged New Zealand men and women: a prospective study.
Metcalf PA; Scragg RK; Swinburn BA; Shaw LM
Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):298-305. PubMed ID: 11887426
[TBL] [Abstract][Full Text] [Related]
29. Application of simple lipid treatment goals in patients with atherosclerotic disease.
Svilaas A; Walsöe HK; Ose L
Nutr Metab Cardiovasc Dis; 2000 Apr; 10(2):71-8. PubMed ID: 10919171
[TBL] [Abstract][Full Text] [Related]
30. Post-marketing surveillance of probucol (Sinlestal) in Japan.
Kosasayama A; Yoshida M; Okada S
Artery; 1992; 19(3):147-61. PubMed ID: 1637256
[TBL] [Abstract][Full Text] [Related]
31. [Effect of tibric acid (CP-18.254) on plasma lipids in patients with primary endogenous hyperlipoproteinemia].
Lisch HJ; Sailer S; Braunsteiner H
Arzneimittelforschung; 1977; 27(10):2017-20. PubMed ID: 579116
[TBL] [Abstract][Full Text] [Related]
32. [Therapeutic effects of nicofibrate on diabetic hyperlipemia].
Gragnoli G; Postorino G; Tanganelli I; Brandi L
Minerva Med; 1977 Apr; 68(19):1281-92. PubMed ID: 323747
[TBL] [Abstract][Full Text] [Related]
33. Response of plasma lipid fractions to the administration of exogenous phospholipids.
Campanacci L; Guarnieri G; Faccini L; Bellini G
Arzneimittelforschung; 1975 Aug; 25(8):1306-8. PubMed ID: 170948
[TBL] [Abstract][Full Text] [Related]
34. Gemfibrozil in a group of diabetics.
de Salcedo I; Gorringe AL; Silva JL; Santos JA
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):64-70. PubMed ID: 1019155
[TBL] [Abstract][Full Text] [Related]
35. More exercise for the hyperlipidaemic patients?
Hanefeld M; Fischer S; Julius U; Leonhardt W; Schubert E; Beckert H
Ann Clin Res; 1988; 20(1-2):77-83. PubMed ID: 3408219
[TBL] [Abstract][Full Text] [Related]
36. Lipid patterns in haemodialysed and transplanted patients.
Ponticelli C; Barbi G; Mecca G; Cantaluppi A; Annoni G; Mauri F; Brancaccio D
Proc Eur Dial Transplant Assoc; 1976; 12():403-11. PubMed ID: 180524
[TBL] [Abstract][Full Text] [Related]
37. Effect of intravenous injection of CDP-choline, S-adenosyl-methionine and citiolone in subjects with hyperlipemia.
Galeone F; Salvadorini F; Guarguaglini M; Saba P
Artery; 1979 Feb; 5(2):157-69. PubMed ID: 231953
[TBL] [Abstract][Full Text] [Related]
38. The use of gemfibrozil in the treatment of primary hyperlipoproteinaemia. Preliminary report.
Honorato J; Masso RM; Purroy A
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):78-9. PubMed ID: 798200
[No Abstract] [Full Text] [Related]
39. [The clinical use of bis-(hydroxy-ethyl-thio)-1,10-decane in the treatment of hyperlipemic and dyslipemic conditions].
Vailati G; Montini M; Simonutti M; Nosari I; Pagani G
Clin Ter; 1978 May; 85(4):361-73. PubMed ID: 668273
[No Abstract] [Full Text] [Related]
40. A long-term trial of gemfibrozil in the treatment of hyperlipidaemias.
Eisalo A; Manninen V
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):49-52. PubMed ID: 798198
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
